APA (7th ed.) Citation

Z, S., BJ, L., É, R., MF, L., X, L., VM, E., . . . S, Z. (2020). Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo. Nucleic acids research, 48(17), 9694. https://doi.org/10.1093/nar/gkaa718

Chicago Style (17th ed.) Citation

Z, Shao, Lee BJ, Rouleau-Turcotte É, Langelier MF, Lin X, Estes VM, Pascal JM, and Zha S. "Clinical PARP Inhibitors Do Not Abrogate PARP1 Exchange at DNA Damage Sites in Vivo." Nucleic Acids Research 48, no. 17 (2020): 9694. https://doi.org/10.1093/nar/gkaa718.

MLA (9th ed.) Citation

Z, Shao, et al. "Clinical PARP Inhibitors Do Not Abrogate PARP1 Exchange at DNA Damage Sites in Vivo." Nucleic Acids Research, vol. 48, no. 17, 2020, p. 9694, https://doi.org/10.1093/nar/gkaa718.